Decibel Therapeutics is Drug Discovery in United States that focus on Decibel Therapeutics Inc business. Founded in 2015. They cover business area such as Decibel Therapeutics Inc, transformative treatment, hearing, balance disorder, regeneration, functional hair cell, non-sensory support cell, its lead gene therapy product candidate, DB-OTO, individual, an OTOF deficiency, DB-ATO, Cochlear Hair Cell Regeneration.
2015
( 11 years old in 2026 )
Decibel Therapeutics Inc
-
1325 Boylston Street
Suite 500
Boston, MA 02215
United States
Private
Decibel Therapeutics Inctransformative treatmenthearingbalance disorderregenerationfunctional hair cellnon-sensory support cellits lead gene therapy product candidateDB-OTOindividualan OTOF deficiencyDB-ATOCochlear Hair Cell Regeneration
* We use standard office opening hours in near Decibel Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Decibel Therapeutics is Drug Discovery business from United States that founded in 2015 (11 years old in 2026), Decibel Therapeutics business is focusing on Decibel Therapeutics Inc.
Decibel Therapeutics headquarter office and corporate office address is located in 1325 Boylston Street Suite 500 Boston, MA 02215 United States.
Decibel Therapeutics was founded in United States.
In 2026, Decibel Therapeutics is currently focus on Decibel Therapeutics Inc sector.
Above is snippet of Google Trends for "Decibel Therapeutics Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Decibel Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
